Work

Phase II trial of sequential bevacizumab (B), erlotinib (E) and chemotherapy for first line treatment of clinical stage IIIB or IV non-small cell lung cancer (NSCLC)

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.19130

Authors: L. Faoro, E. E. Cohen, R. Govindan, M. F. Kozloff, P. C. Hoffman, M. L. Maitland, K. Verel, L. Szeto, R. Salgia, E. E. Vokes

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W23341614

Cites:

Cited by: 6

Related to: 10